Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable.
about
The Cryptococcus neoformans capsule: a sword and a shield.Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosisA role for LHC1 in higher order structure and complement binding of the Cryptococcus neoformans capsuleCapsule independent uptake of the fungal pathogen Cryptococcus neoformans into brain microvascular endothelial cellsRole of CD45 signaling pathway in galactoxylomannan-induced T cell damage.Pbx proteins in Cryptococcus neoformans cell wall remodeling and capsule assembly.The microbial capsular polysaccharide galactoxylomannan inhibits IL-17A production in circulating T cells from rheumatoid arthritis patients.Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity.Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis.Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.Emerging themes in cryptococcal capsule synthesisChronological aging is associated with biophysical and chemical changes in the capsule of Cryptococcus neoformansUnusual galactofuranose modification of a capsule polysaccharide in the pathogenic yeast Cryptococcus neoformans.Disease-enhancing antibodies improve the efficacy of bacterial toxin-neutralizing antibodiesCryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy.What makes Cryptococcus gattii a pathogen?Immunoproteomics and immunoinformatics analysis of Cryptococcus gattii: novel candidate antigens for diagnosis.Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter.Distribution of the O-acetyl groups and β-galactofuranose units in galactoxylomannans of the opportunistic fungus Cryptococcus neoformans.Involvement of the capsular GalXM-induced IL-17 cytokine in the control of Cryptococcus neoformans infection
P2860
Q24619875-505FD511-2571-48F1-9C23-7C68A526BF66Q28482168-4E37F6B3-F473-4398-8C7B-5F08FE325664Q28538344-2D4B46BF-1B59-4699-B2BA-BEE781465E1EQ28730545-DC80B37D-A495-4A21-901A-9A55E966BB6EQ33697916-351CB9E9-F1C8-47DD-AA0A-52F753AC220DQ33766799-8F4A4254-5F29-4316-BC84-8A2B5FC9AE55Q34544926-E98C7988-0592-4AA7-8513-DE52CCDB9E6CQ34561087-AC99433D-C97C-4A3E-AA4C-DC74A03DEADEQ34594241-4CA33B4D-68B4-4444-9533-0A1CB51E476AQ34775729-93B7682F-DF03-439E-A05E-DB8FDD6EEA0FQ35291602-6137A90A-3A04-43F9-983D-8463897947C9Q35598044-17E229AF-3D07-4BFF-9484-936806846949Q36779547-C14C6AF4-A717-4348-B484-BA9A97A8528EQ36786293-86BF67D4-572B-4C9D-AB1C-EC094BAFB12AQ37917789-69DCE47A-D848-4FF8-8887-AF2B8BB35FD6Q38650835-95ABFC80-A077-4188-B9BF-54E934190D36Q39444326-65A58FF2-1418-476D-9409-C97085208B10Q39693119-B623A62D-F471-455E-BF1A-DB206A411C3FQ46444722-9B4FF29D-9B84-43F2-9A8D-D2ED1D6C295EQ58608737-76AEE3BA-79DF-49BA-B306-CEDED4CDFB95
P2860
Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Galactoxylomannans from Crypto ...... ly and antigenically variable.
@ast
Galactoxylomannans from Crypto ...... ly and antigenically variable.
@en
Galactoxylomannans from Crypto ...... ly and antigenically variable.
@nl
type
label
Galactoxylomannans from Crypto ...... ly and antigenically variable.
@ast
Galactoxylomannans from Crypto ...... ly and antigenically variable.
@en
Galactoxylomannans from Crypto ...... ly and antigenically variable.
@nl
prefLabel
Galactoxylomannans from Crypto ...... ly and antigenically variable.
@ast
Galactoxylomannans from Crypto ...... ly and antigenically variable.
@en
Galactoxylomannans from Crypto ...... ly and antigenically variable.
@nl
P2093
P2860
P356
P1433
P1476
Galactoxylomannans from Crypto ...... ly and antigenically variable.
@en
P2093
Magdia De Jesus
Radames J B Cordero
Siu-Kei Chow
Susana Frases
P2860
P304
P356
10.1128/EC.00268-09
P577
2010-01-08T00:00:00Z